Deficient CCR7 signaling promotes TH2 polarization and B-cell activation in vivo



The chemokine receptor CCR7 has a central role in regulating homing and positioning of T cells and DCs to lymph nodes (LNs) and participates in T-cell development and activation. In this study, we addressed the role of CCR7 signaling in TH2 polarization and B-cell activation. We provide evidence that the lack of CCR7 drives the capacity of naïve CD4+ T cells to polarize toward TH2 cells. This propensity contributes to a lymph node environment in CCR7-deficent mice characterized by increased expression of IL-4 and increased frequency of TH2 cells. We show that elevated IL-4 levels lead to B-cell activation characterized by up-regulated expression of MHC class II, CD23 and CD86. Activated B cells are in turn highly efficient in presenting antigen to CD4+ T cells and thus potentially contribute to the TH2 microenvironment. Taken together, our results support the idea of a CCR7-dependent patterning of TH2 responses, with absent CCR7 signaling favoring TH2 polarization, dislocation of T helper cells into the B-cell follicles and, as a consequence, B-cell activation.


The chemokine receptor CCR7 is expressed on several cells of the immune system including mature DCs, activated plasmacytoid DCs (pDCs), naïve and central memory T cells, as well as B cells 1–4. The ligands for CCR7, the chemokines CCL19 and CCL21, are homeostatically expressed in lymphoid organs as well as in terminal lymphatic vessels and play an important role in the homing of DCs and lymphocytes to secondary lymphoid organs (SLOs) and their positioning within defined compartments therein 5. CCR7−/− mice display a severely altered micro-architecture in SLOs reflecting the profound defects of T-cell and DC homing 6. Surprisingly, CCR7−/− mice are not immunodeficient in a strict sense as they have been reported to display exacerbated contact hypersensitivity responses to oxazolone and enhanced immune reactions after immunization with tetanus toxoid 7. Furthermore, CCR7−/− mice are able to elicit a robust antiviral B-cell response following VSV infection leading to similar VSV-specific Ig titers in WT and CCR7−/− mice 8. CCR7−/− mice also display elevated serum titers of IgG to dsDNA in serum and IgG deposits in renal glomeruli, reflecting their high propensity to develop autoimmunity 9. B cells are present in regular numbers in LNs of CCR7−/− mice, but these cells display several deviations from the phenotype of WT cells. B cells isolated from the peripheral lymph nodes (pLNs) of CCR7−/− mice express increased levels of surface MHC class II (MHC-II), and IgD IgMlow B cells are present at higher frequencies. Furthermore, altered isotype switching is observed in CCR7−/− mice 6. It is currently unclear whether this altered B-cell phenotype is a consequence of an inherent B-cell defect or whether it is due to the altered microenvironment in LNs of CCR7−/− mice, reflecting possibly aberrant cell–cell interactions and/or altered secretion of soluble factors. Moreover, in addition to the well-established role of CCR7 as a homing receptor directing the migration of cells into SLOs, increasing evidence suggests that CCR7-mediated signals contribute to other cellular processes such as modulation of cell proliferation, activation or differentiation 10–12.

In the present study, we reveal the mechanisms that cause B-cell activation in the non-inflamed LNs in CCR7−/− mice. Applying adoptive cell transfers we show that factors within the LNs environment determine the level of B-cell activation irrespective of their CCR7 expression. With RT-PCR and in vivo neutralization experiments, we provide evidence that IL-4 is over-expressed in pLNs of CCR7−/− mice and significantly contributes to the activation of B cells. Furthermore, we demonstrate that upon T-cell stimulation and TH2 polarization, CCR7−/− CD4+ T cells differentiate with higher frequency to IL-4-secreting cells than CCR7+/+ CD4+ T cells. Taken together, we provide evidence that deficient CCR7 signaling fosters a TH2 environment in LNs with increased IL-4 secretion from CD4+ T cells and activation of B cells. These results reveal new aspects of CCR7 function in the homeostasis of the immune system, complementing its known role in cell migration.


B cells in pLNs of CCR7−/− mice are activated

In order to identify the mechanisms underlying increased surface MHC-II levels on B cells we described earlier in CCR7−/− mice 6, the expression of cell surface levels of MHC-II, as well as other activation markers such as CD86, and the low-affinity Fcε receptor (CD23) was analyzed. Compared with Balb/c mice, B cells residing in pLNs of CCR7−/− mice display an activated phenotype with significantly increased expression of MHC-II, CD86 and CD23 (Fig. 1A). Semi-quantitative analysis revealed an approximately 2.5-fold increase in MHC-II and CD86, whereas CD23 was approximately twofold up-regulated. While in CCR7−/− mice CD23 was also up-regulated on blood and splenic B cells, we failed to observe any difference between the two genotypes regarding MHC-II or CD86 expression on B cells isolated from spleen or blood (Fig. 1B). Similar results were obtained with CCR7−/− mice on the C57BL/6 genetic background (Supporting Information Fig. 1). To test the idea that up-regulation of these markers is caused by a potentially increased pathogenic load in CCR7−/− mice, we also analyzed WT and CCR7−/− mice kept under germ-free conditions. Up-regulation of MHC-II and CD86 was also observed on B cells in CCR7−/− mice kept under germ-free conditions, suggesting that intrinsic – rather than microbial-factors are responsible for B-cell activation in CCR7−/− mice (Supporting Information Fig. 2). We found a similarly altered activation status of B cells in plt/plt mice (Supporting Information Fig. 1), which carry a spontaneous genetic deletion that prevents the expression of the CCR7 ligands, CCL19 and CCL21 in SLOs 13, suggesting that the absence of signaling through CCR7 and not merely CCR7 deficiency is responsible for the altered B-cell phenotype.

Figure 1.

B cells are activated in the pLNs of CCR7−/− mice. (A) Flow cytometry plots show the expression of MHC-II, CD86 and CD23 on CD19+ cells from pLNs, spleen and peripheral blood in BALB/c (solid line) and BALB/c-CCR7−/− mice (dashed line). Fluorescence minus one (FMO) controls for both genotypes are shown in gray-shaded histograms. (B) Quantitation of results shown in (A). Data are presented as mean±SD of three mice per group. Representative results are shown from one of three to five independent experiments. (C) CD19+ cells were sorted from pLNs of CCR7−/− and WT mice and subjected to microarray analysis as described in Materials and Methods. The x-axis depicts log2 transformed values of relative gene expression levels in CCR7−/− B cells versus WT B cells; x-axis labels were re-converted into fold change values. Only genes with an established role in B-cell activation processes were selected for presentation. Bars represent mean and dots represent the range of ratio values calculated from two individual experiments. (D) Uniform transcript expression of MHC-II genes in B cells isolated from pLNs of WT and CCR7−/− mice. Relative expression of MHC-II genes was determined with RT-PCR. Data are presented as the mean and range of ratio values from three independent experiments.

To delineate further effects of CCR7 deficiency on gene expression in B cells, highly purified CD19+ cells from pLNs of CCR7−/− mice or WT controls were sorted and subjected to whole mouse genome microarray analysis (GEO accession: GSE27885). Very few genes were differentially regulated in CCR7−/− B cells and the differences in mRNA expression were only minor. Out of the 15 547 functionally annotated mRNA transcripts analyzed, only 12 were >2-fold over-expressed and 21 transcripts were >2-fold down-regulated in CCR7−/− B cells in each of two experiments performed (Supporting Information Table 1). Genes with deregulated expression and being known for having a role in B-cell activation are presented in Fig. 1C. The expression of Immunoglobulin joining chain (Igj), Activation-induced cytidine deaminase (Aicda), Secretory leukoprotease inhibitor (Slpi), Nuclear factor, IL-3-regulated (Nfil3) and SAM domain, SH3 domain and nuclear localization signals, 1 (Samsn1) was up-regulated 4.8-, 3.3-, 3.1-, 3.1- and 2.7-fold, respectively, in CCR7−/− B cells. For all these genes increased transcripts upon B-cell activation have been reported, especially in response to IL-4 as regards Aicda, Nfil3 and Samsn1 14–18. mRNA expression levels of Krüppel-like factor 4 (Klf4) and regulators of G-protein signaling 1 and 2 (Rgs1 and Rgs2) were down-regulated 2.5-, 4.6- and 2.9-fold, respectively, in CCR7−/− B cells. KLf4 expression has been reported to increase during B-cell maturation and to decrease upon B-cell activation 19. Rgs1 and Rgs2 down-regulate chemotaxis to lymphoid chemokines and their expression levels were shown to vary considerably depending on the B-cell activation regimen applied 20. Genes encoding the β chain of H2-A and H2-E molecules were not expressed differentially between CCR7−/− and WT B cells. This finding was also verified by RT-PCR analysis (Fig. 1D). Together, these data suggest that only few genes are differentially expressed in B cells from CCR7−/− mice and some of them have been associated with B-cell activation. Furthermore, the up-regulation of MHC-II observed on CCR7−/− B cells is not caused by enhanced transcription of MHC-II genes in these cells.

MHC-II endocytosis rate is reduced in CCR7−/− B cells

Since we could not find any difference in MHC-II expression at the mRNA level, we investigated the kinetics of MHC-II internalization and recycling by flow cytometry. WT or CCR7−/− B cells were labeled on ice with anti CD19-Cy5 and biotinylated anti-I-Ab, washed and then incubated for different time periods at 37°C. The cells were then immediately washed on ice, and the amount of MHC-II remaining on the cell surface was revealed with streptavidin-PerCp. MHC-II was internalized rapidly in CCR7+/+ as well as CCR7−/− B cells. In both cell populations, approximately 50% of the initial MHC-II amount remained on the cell surface after 30 min, while equilibrium was reached after 60 min (Fig. 2A). However, for all time points investigated, the rate of MHC-II endocytosis was significantly decreased in CCR7−/− B cells (Fig. 2A). We also investigated the amount of MHC-II that recycled back to the cell surface from internal stores, or was newly translated, for the same time periods as described in the previous experiment. For this purpose, B cells were labeled as described above and after incubation at 37°C were immediately washed on ice followed by staining with anti-I-Ab-FITC to reveal re-expressed MHC-II on the cell surface. The recycling kinetics of MHC-II to the cell surface were similar in CCR7+/+ and CCR7−/− B cells (Fig. 2B). Together, these results suggest that the elevated expression of MHC-II on the cell surface of CCR7−/− B cells is caused, at least to a certain extent, by a reduced MHC-II endocytosis rate.

Figure 2.

Reduced rate of MHC-II endocytosis in CCR7−/− B cells. (A) Single-cell suspensions generated from pLNs of CCR7−/− and WT mice were stained on ice with anti-CD19 to identify B cells and biotinylated anti-I-Ab. The cells were then washed and incubated at 37°C for different periods of time as indicated. After incubation, cells were immediately washed extensively on ice and stained with a fluorescently labeled streptavidin to reveal the remaining amount of MHC-II molecules on the cell surface, or as depicted in (B), with anti-I-Ab, recognizing the same epitope as the biotinylated anti-I-Ab used in the initial staining, to reveal MHC-II molecules recycling to the cell surface. The MFI of MHC-II on B cells was measured by flow cytometry and is expressed as a percentage of the MHC-II MFI on the surface of B cells that were not incubated at 37°C. For direct comparison of MHC-II modulation, MFI values of non-incubated WT (filled circles) and CCR7−/− B cells (open circles) were each set to 100%. Data are presented as mean±SD of four mice per group. Results are shown from one of three independent experiments. *p<0.05, **p<0.01, unpaired two-tailed t-test.

CCR7−/− B cells prime CD4+ T cells more efficiently than WT B cells

B cells can contribute as highly competent APCs to CD4+ T-cell activation 21, 22. Thus, we tested whether the altered activation phenotype of CCR7−/− B cells is also associated with more efficient Ag presentation. The capacity of WT and CCR7−/− B cells for Ag processing and presentation was assessed in vitro with a 3H-thymidine T-cell proliferation assay. Purified B cells from CCR7−/− or WT mice were irradiated, incubated overnight with OVA323–339-peptide or OVA protein and co-cultured with OT-II CD4+ T cells for 3 days. For all concentrations of OVA323–339-peptide tested, CCR7−/− B cells induced significantly higher CD4+ T-cell proliferation compared with CCR7+/+ B cells. While the increase in T-cell proliferation was on average approximately twofold in the case B cells were pulsed with the peptide (Fig. 3A), an approximately 3-fold increase was observed for CCR7−/− B cells loaded with OVA protein (Fig. 3B). These observations suggest that the altered activation status of CCR7−/− B cells is also associated with very efficient Ag processing and presentation.

Figure 3.

CCR7−/− B cells prime CD4+ T cells very efficiently. (A) MACS-purified B cells from CCR7−/− (open bars) and WT mice (filled bars) were irradiated, pulsed overnight with different concentrations of OVA323–339 peptide and used as stimulators for CD4+ T cells isolated from OT-II mice. The T-cell/B-cell ratio was 1:1. T-cell proliferation was assessed after 3 days of co-culture in a 3H-thymidine incorporation assay. (B) Same experimental procedure as that described in (A), but using 1 mg/mL OVA protein as Ag. Data are presented as mean±SD of quadruplicate cultures. Representative results are shown from one of three (A) or two (B) independent experiments. Statistical significance was determined by the unpaired two-tailed t-test.

The altered cytokine milieu in pLNs of CCR7−/− mice activates B cells

To address the question whether B cells in CCR7−/− mice are activated due to a B-cell defect per se or due to the altered milieu present in pLNs in CCR7−/− mice, we performed adoptive transfers of either CCR7−/− or CCR7+/+ B cells in both WT and CCR7−/− recipients. Ly5.1 donor B cells were transferred by i.v. injection to Ly5.2 WT and Ly5.2 CCR7−/− recipients. In the reverse experiment, TAMRA-labeled CCR7−/− donor B cells were transferred to CCR7−/− and WT recipients. Forty-eight hours after cell transfer, the activation status of donor B cells in pLNs was measured by FACS. CCR7−/− B cells that were introduced into the environment of WT pLNs significantly down-regulated their MHC-II expression, while CCR7+/+ B cells introduced into the environment of CCR7−/− pLNs significantly up-regulated their MHC-II expression (Fig. 4A). These results suggest that B cells of CCR7–/– mice do not carry an intrinsic defect that might account for their activated phenotype rather that the disturbed micromilieu of SLOs in CCR7−/− mice constitutes a B-cell activating environment.

Figure 4.

The pLNs of CCR7−/− mice exhibit a TH2 cytokine milieu. (A) Single-cell suspensions of TAMRA-labeled splenocytes from C57BL/6 CCR7−/− or splenocytes from C57BL/6 Ly5.1 donor mice were adoptively transferred by i.v. injection in WT or CCR7−/− recipients (recip.) as indicated. Recipients were sacrificed 48 h after transfer and MHC-II surface expression on donor B cells in pLNs was analyzed by flow cytometry (mean±SD of four mice per group). Representative results from one of three independent experiments are shown. (B) Homogenized tissue samples of pLNs from CCR7−/− and WT mice were assayed with RT-PCR for IL-4 and IFN-γ gene expression. The y-axis shows the relative expression levels in CCR7−/− versus WT samples (mean±SEM; n=3 independent experiments). (C) CCR7−/− mice were injected i.p. with either 0.9 mg of anti-IL-4 or 0.6 mg of anti-IFN-γ or both Abs. Twenty-four hours after injection, mice were sacrificed and MHC-II (left) as well as CD86 expression (right) on B cells from pLNs was measured by flow cytometry. MFI values are plotted as a percentage of values obtained from CCR7−/− mice injected with PBS, serving as control. Data are presented as mean±SEM of six mice per group. Results are shown from three pooled independent experiments. (A and C) Statistical significance was determined by the unpaired two-tailed t-test.

To test the possibility that an altered cytokine milieu in pLNs of CCR7−/− mice is responsible for the activation of B cells, we performed RT-PCR analysis of transcripts for IL-4 and IFN-γ. Both prototypic cytokines that functionally define TH2 or TH1 immune responses respectively, have been shown to modulate B cell functions 23. In particular, IL-4 has been described to efficiently activate B cells resulting amongst others in the up-regulated expression of MHC-II, CD23 and CD86 23–25. Total RNA from pLNs was reverse transcribed to cDNA, and the expression of Il4 and Ifng genes was assessed by RT-PCR. Of interest, IL-4 mRNA was approximately 23-fold enriched in pLNs of CCR7−/−mice, while IFN-γ mRNA was expressed to a similar level in pLNs of CCR7−/− and WT mice (Fig. 4B). Expression of both IL-4 mRNA and IFN-γ mRNA was normalized to hprt.

To substantiate the role of IL-4 in the B-cell activation observed in pLNs of CCR−/− mice, we performed in vivo IL-4 and/or IFN-γ neutralization assays. To this end, CCR7−/− mice were injected i.p. with either anti-IL-4 or anti- IFN-γ, or both neutralizing antibodies together. After 24 h, mice were sacrificed and MHC-II as well as CD86 surface expression levels of B cells in pLNs were assessed by flow cytometry. When compared with the negative control group injected with PBS, we failed to observe any significant effect of IFN-γ blocking on MHC-II and CD86 expression. In contrast, anti-IL-4  mAb treatment led to a significant down-regulation of surface MHC-II and CD86 on B cells of CCR7−/− mice (Fig. 4C). Furthermore, the combined application of anti IL-4 and anti IFN-γ neutralizing Abs induced a similar impairment of B-cell activation as sole anti-IL-4 treatment. These data suggest that pLNs in CCR7−/− mice harbor a TH2 cytokine milieu characterized by abundant IL-4 expression and that this IL-4, but not IFN-γ, plays a significant role for the constitutive activation of B cells observed in pLNs of CCR7−/− mice.

CCR7−/− CD4+ T cells express higher levels of IL-4 in pLNs than WT CD4equation image T cells

In order to assess the cellular source of IL-4 in pLNs of CCR7−/− mice, we investigated the IL-4 secretion potential of T cells. For this purpose, single-cell suspensions from pLNs of CCR7−/− and WT mice were stimulated for 4 h with PMA/ionomycin and IL-4 secretion from CD4+ T cells was determined on single-cell level using the IL-4 secretion assay. We found approximately four times more IL-4-producing cells in pLNs of CCR7−/− mice but no significant difference in IFN-γ expressing cells, further substantiating the hypothesis that a TH2 environment is present in CCR7−/− mice (Fig. 5A). There were no significant differences between WT and CCR7−/− splenic CD4+ T cells regarding IL-4 secretion. However, cells in spleens of WT mice produced approximately three times more IFN-γ (Fig. 5B). Finally, to test the hypothesis that the absence of CCR7 on T cells affects their TH2 polarization potential, we subjected naïve (CD62L+CD44) CD4+ T cells sorted from LNs to TH2-specific polarization in vitro. Cells were activated by anti-TCR-β, anti-CD28 and IL-2 under TH2 conditions for 5 days. During the last 4 h of culture, the cells were restimulated with PMA/ionomycin, and IL-4 expression of CD4+ T cells was assessed with the IL-4 secretion assay. Under these conditions, approximately 5% of CCR7+/+ CD4+ T cells produced IL-4, whereas about 10% of CCR7−/− CD4+ T cells were positive for secreted IL-4 (Fig. 5C). Together these data suggest that CCR7−/− CD4+ T cells in pLNs are more prone to differentiate in the TH2 direction than CCR7+/+ CD4+ T cells, contributing to the IL-4-rich environment in pLNs of CCR7−/− mice.

Figure 5.

CCR7−/− CD4+ T cells in pLNs exhibit a high intrinsic TH2 polarization potential. (A) Single-cell suspensions from pLNs of WT and CCR7−/− mice were stimulated for 4 h with PMA/ionomycin in complete RPMI. IL-4 secretion by CD4+ T cells was determined with the IL-4 secretion assay. For detection of IFN-γ production, brefeldin A was added for the last 2 h of culture and IFN-γ-expressing cells were identified by intracellular staining. (B) The same analyses were performed for cells isolated from spleens of WT and CCR7−/− mice. Representative flow cytometry plots and quantitation of data are shown from one of two independent experiments (four mice per group). Numbers in gates present percent of CD4+ T cells expressing IL-4 or IFN-γ. (C) Naïve CD4+ T cells were FACS-sorted from LNs and cultured under TH2 conditions for 5 days. After restimulation with PMA/ionomycin cells were subjected to the IL-4 secretion assay, and IL-4 production was measured by flow cytometry. Representative plots and quantitation of data (right) are shown from three pooled independent experiments. Data are presented as mean±SD of triplicate cultures per experiment. Statistical significance was determined by the unpaired two-tailed t-test.


In addition to its role in cell homing, recent data suggest that CCR7 delivers signals that contribute to T-cell velocity 26, T-cell expansion as well as differentiation. CCL21, produced by LN stroma cells, but also present on the surface of DCs, delivers co-stimulatory signals during early TCR activation, leading to enhanced IFN-γ production and TH1 polarization 12, 27. Thus, active CCR7 signaling seems to favor TH1 polarization of T cells. Our data support this idea, since the absence of CCR7 signals skews the differentiation of T cells to the TH2 direction. Compared with WT controls, massively increased levels of IL-4 mRNA are found in LNs of CCR7−/− mice and more IL-4-producing CD4+ T cells are present in the LNs of these animals. Apart from CD4+ T cells, approximately 0.15% of B cells secreted IL-4 in LNs of CCR7−/− mice. In the CD8+ T-cell population and the CD3B220 population, no IL-4 secreting cells could be identified (data not shown). The increased levels of IL-4 probably contribute to the approximately 20-fold increase in serum IgE observed earlier in CCR7−/− mice 6. Using highly purified naïve CD4+ T cells in TH2 polarization assays, our data suggest that the absence of CCR7 on CD4+ cells (and thus signals mediated via this receptor) directly contribute to T-helper-cell polarization since twice as many CCR7−/− T cells gained a TH2 phenotype compared with WT cells. However, since CCR7 deficiency also affects the homing of several cell types into LNs, we cannot exclude additional factors contributing to the TH2 environment in these mice. Furthermore, detection of IL-4 by standard methods such as intracellular staining or secretion assay reveals only a fraction of IL-4-producing T cells when compared with the detection of IL-4 transcription levels using IL-4-reporter mice 28. This discrepancy along with yet unknown factors might help to explain why IL-4 transcript levels were considerably higher than the number of IL-4-producing T cells in CCR7−/− mice. In particular, the impairment of CCR7−/− DCs to home to LNs following their activation in the periphery affects antigen presentation in these mice which also might have an effect on T-cell polarization. Furthermore, the positioning of those T cells which successfully homed to LNs in CCR7−/− mice is considerably different from the WT situation. While B and T cells, to a large degree, are separated in WT animals, these cells are not clearly segregated in CCR7−/− animals, with large numbers of CD4+ T cells invading the B-cell follicles 29 (see also Supporting Information Fig. 3). This delocalization of T cells allows multiple interactions with B cells and potentially contributes to their activation in LNs of CCR7−/− mice.

Of interest, using Leishmania major infection in IL-4 reporter (4-get) mice Reinhardt et al. 30 recently reported that not the classical TH2 cells but rather T follicular helper (TFH) cells are the main producers of IL-4 in vivo. Among others, TFH cells are characterized by the expression of CD154, a potent B-cell activator, ICOS, PD-1, as well as the expression of CXCR5 and the absence of CCR7. Previous studies from our own group and others have shown that the localization of TFH cells in SLOs is determined by the balanced expression of CCR7 and CXCR5 29, 31. While the lack of CXCR5, a receptor for CXCL13 produced by follicular DCs, prevents migration of TFH cells from the T-zone to B-cell follicles, the lack of CCR7 disrupts T-zone retention signals and allows translocation of all CXCR5+ cells to the follicle. IL-4-producing CD4+ T cells in pLNs of CCR7−/− mice exhibit a similar localization pattern to TFH cells, and a significant proportion of these cells co-expresses the characteristic TFH markers ICOS and PD-1 (Supporting Information Fig. 4). Thus, it is plausible that not only a shifted TH2 polarization but also displacement of activated T cells into the B-cell follicle are causative for the activated B cells found in LNs of CCR7−/− mice.

Several signals are known to be required for efficient B-cell activation including Ag engagement of the BCR, ligation of CD40 by CD154, presence of DCs as well as IL-4 provided by activated CD4+ T cells and DCs 32, 33. CD40 signaling sustains B-cell activation and leads to several modifications in the Ag processing and presentation machinery 34. These changes include enhanced Ag processing, up-regulation of MHC-II and stabilization of CD86 expression 35. Thus, the process of B-cell activation is highly dependent on interactions with T cells and DCs, both being severely affected in CCR7−/− mice 6. Applying adoptive B-cell transfers, we could demonstrate that CCR7 deficiency on B cells does not directly lead to the activation of these cells, but that environmental factors within the pLNs of CCR7−/− mice lead to B-cell activation. Using neutralizing antibodies, these experiments revealed IL-4 as a key component that leads to MHC-II and CD86 up-regulation on B cells. Several reports have addressed the role of IL-4 in B-cell activation. IL-4 leads to up-regulation of MHC-II, CD23 on B cells and induction of IgE production 23, 24, 36, 37. Similar effects were observed in studies assessing the effects of IL-4 and IL-13 in human B cells 38–40. IL-4 is not only a major B-cell activating factor that is effectively produced by helper CD4+ T cells but, through a positive feedback loop, it reinforces TH2 polarization of CD4+ T cells 41 thus contributing to increase IL-4 in LNs of CCR7−/− mice. Furthermore, as outlined above, CD4+ T cells in pLNs of CCR7−/− mice are displaced to a large degree to the B-cell follicle and, thus, it seems possible that B cells get not only activated via secreted IL-4 but also by CD40 signaling induced by membrane-bound CD154. Of interest, activated B cells have been reported to be able to elicit their own help from T cells and to induce TH2 differentiation of CD4+ T cells through efficient Ag presentation 42. Since B cells in CCR7−/− mice not only show an activated phenotype but also efficiently present Ag to CD4+ T cells, it seems possible that these cells provide a feedback loop that contributes to the extended TH2 polarization in these animals. The strong T-cell priming capabilities of CCR7−/− B cells can be probably attributed to the enhanced co-stimulation provided by the abundant CD86 expression and increased amounts of Ag presented in the elevated levels of surface MHC-II molecules. These properties likely account for the significantly higher T-cell proliferation observed. However, we can currently not exclude that additional factors contribute to this effect.

A number of reports assessed the role of CCR7 signaling in the induction of TH2 responses. Employing a well-established model of OVA mediated allergic airway inflammation, Xu et al. show that plt/plt mice develop a higher allergic inflammation score in the lung including significantly enhanced recruitment of eosinophils and lymphocytes compared with WT mice 43. Furthermore, OVA-specific and total IgE levels were substantially higher in plt/plt mice as well as IL-4 and IL-13 expression levels in the lung when compared with WT mice. In contrast, compared with WT animals the expression of IFN-γ was lower in plt/plt animals. Similar results were obtained in studies by Takamura et al. and Grinnan et al. 44, 45. In summary, these studies provide evidence for enhanced TH2 responses upon immunization in the absence of functional CCR7 signaling.

As it has been reported by Pai et al. 25, the IL-4-induced up-regulation of MHC-II protein expression on B cells is not due to enhanced transcription of MHC-II or CIITA, the master regulator of MHC-II expression. We obtained identical results from our microarray studies and qRT-PCR experiments comparing transcript expression in CCR7−/− versus WT B cells. CIITA and H2 transcripts were not differentially expressed between both genotypes. Accordingly, posttranslational mechanisms have been speculated to be responsible for increased MHC-II expression induced by IL-4 in B cells. By addressing the kinetics of MHC-II internalization and recycling in CCR7−/− B cells we present evidence that a reduced MHC-II endocytosis rate contributes to the up-regulation of MHC-II and by neutralizing IL-4 in vivo we provided substantial evidence for IL-4 significantly contributing to the activation of B cells in CCR7−/− mice. Linking these two findings, we propose a model for an IL-4-mediated reduction of MHC-II endocytosis from the cell surface, at least contributing by as yet unknown mechanisms to the IL-4-mediated MHC-II up-regulation in B cells described here and by others 23, 25.

Taken together, our findings support the hypothesis that signaling through CCR7 affects the TH1/TH2 polarization potential of CD4+ T cells with lack of CCR7 signaling favoring the development of TH2 cells. The increased IL-4 production potentially together with the delocalization of CD4+ T cells into the B-cell follicle contributes to B-cell activation in pLNs of CCR7−/− mice. These activated B cells efficiently prime CD4+ T cells and thus potentially contribute to the TH2 microenvironment in CCR7−/− mice.

Materials and methods


BALB/c CCR7−/− and C57BL/6 CCR7−/− mice as well as BALB/c, C57BL/6, C57BL/6 Ly5.1, OT-II and C57BL/6 plt/plt mice were bred at the animal facility of Hannover Medical School. All mice were maintained under specific pathogen-free conditions and used at the age of 8–12 weeks. Animal experiments were conducted in accordance with local and institutional guidelines.

Antibodies and flow cytometry

Single-cell suspensions from pLNs (pooled inguinal, axillary and brachial LNs), spleen and peripheral blood were incubated for 20 min at 4°C with fluorochrome-labeled Abs in FACS staining buffer (PBS with 3% v/v FCS). Data were collected on a LSR II flow cytometer (BD Biosciences) and were analyzed with FlowJo software (Treestar). The following antibodies were used: anti-I-Ab-bio/FITC, anti-I-Ad-FITC and anti-CD3-PE (all from BD Biosciences); anti-CD23-PE (Caltag); anti-CD86-allophycocyanin, anti-CD45.1-PE, anti-CD62L-allophycocyanin-eFluor® 780, anti-CD44-eFluor® 450 and anti-CD45.2-PerCp Cy5.5 (eBioscience) and anti-CD4-PerCp (BioLegend). The following antibodies were grown at our institutes: anti-TCR-β chain-bio (clone: H57-597), anti-CD19-bio/Cy5 (clone 1D3), anti-IL-4 (clone 11B11), anti-IFN-γ (clone XMG1.2) and anti-B220-PO (clone TIB146). PerCp (BD Biosciences) or Pacific Orange (Invitrogen)-labeled streptavidin was used for the detection of primary biotinylated antibodies. Fluorescence-minus-one (FMO) or isotype control samples were used to assess background fluorescence for each population 46.

Adoptive cell transfers

Single-cell suspensions were prepared from spleens of C57BL/6 Ly5.1 and C57BL/6 CCR7−/− donor mice. Cells from the latter were labeled with 7.5 μM 5- (and -6-) TAMRA SE (Invitrogen) for 15 min at 37°C. C57BL/6 Ly5.2 and C57BL/6 Ly5.2 CCR7−/− mice received 15×106 cells by i.v. injection into the tail vein. Recipient mice were sacrificed 48 h after cell transfer.

T-cell proliferation assays

For T-cell proliferation assays, B cells from WT or CCR7−/− mice were purified by positive selection using mouse CD45R (B220) MicroBeads and AutoMacs (Miltenyi Biotec) resulting routinely in >95% purity of B cells. These cells were irradiated at 30 Gy and pulsed overnight with different concentrations of OVA peptide specific for the TCR expressed by OT-II T cells (OVA323–339 ISQAVHAAHAEINEAGR; peptide (Anaspec)) or with 1 mg/mL OVA grade VI (Sigma-Aldrich). CD4+ T cells from OT-II mice were purified by magnetic sorting using mouse CD4 Dynabeads (Invitrogen) or mouse CD4  T Cell Isolation Kit and AutoMacs (Miltenyi Biotec). Cells were co-cultured in complete RPMI 1640 (10% FCS, β-ME, glutamine, penicillin/streptomycin) at a ratio of 1:1 for 72 h in triplicates, with 0.8 μCi 3H-thymidine added for the last 18 h of culture. Proliferation of CD4+ T cells was determined with a scintillation counter.

T-cell polarization assays

Single-cell suspensions were prepared from LNs or spleens of BALB/c CCR7−/− and BALB/c mice. Cells were stimulated for 4 h with 50 ng/mL phorbol myristate acetate (Sigma-Aldrich) and 500 ng/mL ionomycin (Invitrogen) in complete RPMI and subjected to the Mouse IL-4 Secretion Assay (Miltenyi Biotec) for the detection of IL-4 production according to the instructions of the manufacturer. For intracellular IFN-γ staining, cells were stimulated for 4 h with 50 ng/mL phorbol myristate acetate and 500 ng/mL ionomycin. During the last 2 h of culture, 10 μg/mL Brefeldin A (Sigma-Aldrich) was added. Cells were then fixed and permeabilized using the BD Cytofix/Cytoperm Kit (BD Biosciences). Intracellular cytokine staining was performed using anti-IFN-γ-PE (Biolegend).

For TH2 polarization assays, naïve CD4+ T cells from LNs were sorted on a FACSAria (BD Biosciences) after staining with anti-CD4, anti-CD62L and anti-CD44, to >99% purity. Cells were stimulated in 96-well plates under TH2 conditions as described before in the presence of APCs prepared from spleens of BALB/c mice after γ-irradiation and T-cell depletion. In brief, cells were activated with anti-TCR-β (1 μg/mL, clone H57), anti-CD28 (5 μg/mL, clone 37.51), human recombinant IL-2 (50 U/mL) and differentiated under TH2 conditions with 40 ng/mL murine recombinant IL-4 (PeproTech), 10 μg/mL anti IL-12 (clone C17.8) and 40 μg/mL anti IFN-γ (clone XMG 1.2) 28. Cells were cultured at a ratio of 1:3 (50 000 CD4+ T cells with 150 000 APCs) for 5 days. After 5 days in culture, cells were restimulated with 50 ng/mL phorbol myristate acetate and 500 ng/mL ionomycin for 4 h, and blocking of IL-4 bound to the IL-4R was performed with purified anti-IL-4 (clone BVD6-24G2), 100 μg/mL. For the detection of IL-4-secreting cells, the mouse IL-4 Secretion Assay (Miltenyi Biotec) was used.

MHC-II internalization and recycling assay

Single-cell suspensions from pooled pLNs of WT or CCR7−/− mice were incubated with anti-CD19-APC and biotinylated anti-I-Ab (clone AF6-120.1) on ice. Cells were washed twice with ice-cold FACS buffer. Some aliquots were then further incubated for various time periods ranging from 10 min to 2 h in RPMI 1640 supplemented with 5% FCS at 37°C. The cells were then immediately washed twice in a tenfold volume of ice-cold FACS buffer and stained on ice with streptavidin-PerCP or with anti-I-Ab-FITC (clone AF6-120.1). The MFI of MHC-II was determined by flow cytometry.

Real-time PCR

Total RNA was extracted from pLNs that had been snap-frozen in 0.5 mL of TRIzol reagent (Invitrogen). Samples were thawed, homogenized using a QIAGEN TissueLyser II and total RNA was extracted according to manufacturer's instructions. cDNA was then generated from individual RNA samples using Superscript II Reverse Transcriptase (Invitrogen) and random hexamer primers. The relative expression of the genes of interest was assessed using a LightCycler 2.0 (Roche) and SYBR Premix Ex Taq kit (Takara Bio). cDNA samples were assayed in duplicate. The cycle threshold was used for quantification. Gene expression levels for each individual sample were normalized to HPRT. Relative gene expression (fold change) between samples was calculated using the mathematic model described by Pfaffl 47. The following primers were used:


IL4 (reverse): cgagctcactctctgtggtg;









Primer pairs were designed with Universal Probe Library website (Roche).

Microarray experiments

In two independent experiments, B cells from pLNs of three C57Bl/6-CCR7−/− and three WT mice were sorted on a FACSAria (BD Biosciences) and subjected to total RNA isolation (Nucleospin RNA XS Kit, Macherey & Nagel). Samples from all individuals of the same genotype were pooled (using 9 ng of RNA per individual). The Whole Mouse Genome Oligo Microarray 4×44 K (G4122F, design ID 014868, Agilent Technologies) was utilized in this study. Twenty nanograms of pooled total RNA per condition were used to prepare Cy3-, or Cy5-labeled cRNA (Amino Allyl MessageAmp II Kit; Ambion) according to manufacturer's instructions. Microarrays were co-hybridized with differently labeled material from CCR7−/− versus WT animals in a dual-color setting. Two biological replicate experiments were analyzed by the use of two individual microarrays including a dye-swap. Additional information on methodology and experimental design have been deposited along with complete microarray data in NCBI's Gene Expression Omnibus and are accessible through GEO Series accession number GSE27885 (

Statistical analysis

Statistical analyses were performed with GraphPadPrism 4 software. Unpaired two-tailed t-tests were used to determine any significant differences between sample groups. Bars show mean values, error bars represent SD or SEM.


The authors thank Andreas Krueger and Guenter Bernhardt for fruitful discussions and critical comments on the manuscript. This work was supported by a Deutsche Forschungsgemeinschafts grant KFO 250-FO 334/2-1 to R. F.

Conflict of interest: The authors declare no financial or commercial conflict of interest